Literature DB >> 26239114

Reduction of mixed Mn-Zr oxides: in situ XPS and XRD studies.

O A Bulavchenko1, Z S Vinokurov, T N Afonasenko, P G Tsyrul'nikov, S V Tsybulya, A A Saraev, V V Kaichev.   

Abstract

A series of mixed Mn-Zr oxides with different molar ratios Mn/Zr (0.1-9) have been prepared by coprecipitation of manganese and zirconium nitrates and characterized by X-ray diffraction (XRD) and BET methods. It has been found that at concentrations of Mn below 30 at%, the samples are single-phase solid solutions (MnxZr1-xO2-δ) based on a ZrO2 structure. X-ray photoelectron spectroscopy (XPS) measurements showed that manganese in these solutions exists mainly in the Mn(4+) state on the surface. An increase in Mn content mostly leads to an increase in the number of Mn cations in the structure of solid solutions; however, a part of the manganese cations form Mn2O3 and Mn3O4 in the crystalline and amorphous states. The reduction of these oxides with hydrogen was studied by a temperature-programmed reduction technique, in situ XRD, and near ambient pressure XPS in the temperature range from 100 to 650 °C. It was shown that the reduction of the solid solutions MnxZr1-xO2-δ proceeds via two stages. During the first stage, at temperatures between 100 and 500 °C, the Mn cations incorporated into the solid solutions MnxZr1-xO2-δ undergo partial reduction. During the second stage, at temperatures between 500 and 700 °C, Mn cations segregate on the surface of the solid solution. In the samples with more than 30 at% Mn, the reduction of manganese oxides was observed: Mn2O3Mn3O4 → MnO.

Entities:  

Year:  2015        PMID: 26239114     DOI: 10.1039/c5dt01440a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  1 in total

1.  From spent alkaline batteries to Zn x Mn3-x O4 by a hydrometallurgical route: synthesis and characterization.

Authors:  Lorena Alcaraz Romo; Ana López-Fernández; Irene García-Díaz; Paloma Fernández; Ana Urbieta; Félix A López
Journal:  RSC Adv       Date:  2018-09-28       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.